•
Mar 31, 2023

Acasti Pharma Q4 2023 Earnings Report

EPS
-$0.65
Previous year: -$0.04
+1525.0%
Cash and Equivalents
$27.9M
Previous year: $30.3M
-8.1%
Total Assets
$79.1M
Previous year: $129M
-38.5%

Acasti Pharma

Acasti Pharma